02 May 2017
The FDA has approved Tymlos, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis who are at high risk of fracture.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024